Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Shri Keshav Cements and Infra Ltd
BSE:530977
|
IN |
|
H
|
Hanjin Transportation Co Ltd
KRX:002320
|
KR |
|
Carillion PLC
LSE:CLLN
|
UK |
|
Seah Steel Holdings Corp
KRX:003030
|
KR |
|
N
|
Nahar Spinning Mills Ltd
NSE:NAHARSPING
|
IN |
|
Straits Trading Company Ltd
SGX:S20
|
SG |
|
G
|
GrabAGun Digital Holdings Inc
NYSE:PEW
|
US |
|
NBT Bancorp Inc
NASDAQ:NBTB
|
US |
|
P
|
Priya Ltd
BSE:524580
|
IN |
|
Responsive Industries Ltd
NSE:RESPONIND
|
IN |
|
Domtar Corp
TSX:UFS
|
US |
|
Rossi Residencial SA
BOVESPA:RSID3
|
BR |
|
Canna-Global Acquisition Corp
OTC:CNGL
|
US |
|
Captain Polyplast Ltd
BSE:536974
|
IN |
|
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
|
CN |
|
O
|
Optowide Technologies Co Ltd
SSE:688195
|
CN |
|
V
|
Viet Nam Construction and Import Export Joint Stock Corp
VN:VCG
|
VN |
|
Ruentex Development Co Ltd
TWSE:9945
|
TW |
|
Qualys Inc
NASDAQ:QLYS
|
US |
|
Seoyon Co Ltd
KRX:007860
|
KR |
Cumberland Pharmaceuticals Inc
EPS (Diluted)
Cumberland Pharmaceuticals Inc
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
|
EPS (Diluted)
$0
|
CAGR 3-Years
21%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
EPS (Diluted)
$11
|
CAGR 3-Years
18%
|
CAGR 5-Years
15%
|
CAGR 10-Years
7%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
EPS (Diluted)
$3
|
CAGR 3-Years
5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
14%
|
|
|
Pfizer Inc
NYSE:PFE
|
EPS (Diluted)
$1
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
2%
|
|
|
Merck & Co Inc
NYSE:MRK
|
EPS (Diluted)
$7
|
CAGR 3-Years
8%
|
CAGR 5-Years
21%
|
CAGR 10-Years
17%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
EPS (Diluted)
$22
|
CAGR 3-Years
49%
|
CAGR 5-Years
28%
|
CAGR 10-Years
26%
|
|
Cumberland Pharmaceuticals Inc
Glance View
Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the acquisition, development, and commercialization of prescription products. The company is headquartered in Nashville, Tennessee and currently employs 83 full-time employees. The company went IPO on 2009-08-11. Its portfolio of brands includes Acetadote injection, for the treatment of acetaminophen poisoning; Caldolor injection, for the treatment of pain and fever; Kristalose for oral solution, a prescription laxative, for the treatment of constipation; and Omeclamox-Pak for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease. Its brands also include RediTrex injection, for the treatment of active rheumatoid, juvenile idiopathic and severe psoriatic arthritis, as well as disabling psoriasis; Sancuso transdermal system, for the prevention of nausea and vomiting in patients receiving certain types of chemotherapy treatment; Vaprisol injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; and Vibativ injection.
See Also
What is Cumberland Pharmaceuticals Inc's EPS (Diluted)?
EPS (Diluted)
-0.2
USD
Based on the financial report for Dec 31, 2025, Cumberland Pharmaceuticals Inc's EPS (Diluted) amounts to -0.2 USD.
What is Cumberland Pharmaceuticals Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
3%
Over the last year, the EPS (Diluted) growth was 59%. The average annual EPS (Diluted) growth rates for Cumberland Pharmaceuticals Inc have been 21% over the past three years , 3% over the past five years .
